{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:12:12Z","timestamp":1783743132485,"version":"3.55.0"},"reference-count":44,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,7,10]]},"DOI":"10.1253\/circrep.cr-26-0090","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:09:42Z","timestamp":1779833382000},"page":"1141-1150","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Atrioventricular Synchronous Leadless Pacing in Patients With Atrioventricular Block\u3000\u2015 Results and Implications From an Exploratory Analysis for Japan \u2015"],"prefix":"10.1253","volume":"8","author":[{"given":"Kazuhiro","family":"Satomi","sequence":"first","affiliation":[{"name":"Tokyo Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Soejima","sequence":"additional","affiliation":[{"name":"Kyorin University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Eun","family":"Myung","sequence":"additional","affiliation":[{"name":"Government Affairs and Market Access, Medtronic Korea Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Healthcare Economics and Government Affairs, Medtronic Japan Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Ryschon","sequence":"additional","affiliation":[{"name":"Wing Tech Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Geisler","sequence":"additional","affiliation":[{"name":"Wing Tech Inc."},{"name":"Institute of Social Medicine, Epidemiology &amp; Health Economics, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin &amp; Humboldt Universit\u00e4t zu Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Ikeno","sequence":"additional","affiliation":[{"name":"Wing Tech Inc."},{"name":"Division of Cardiovascular Medicine, School of Medicine, Stanford University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Pietzsch","sequence":"additional","affiliation":[{"name":"Wing Tech Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kirkfeldt RE, Johansen JB, Nohr EA, J\u00f8rgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: An analysis of a complete, nationwide cohort in Denmark. <i>Eur Heart J<\/i> 2014; 35: 1186\u20131194.","DOI":"10.1093\/eurheartj\/eht511"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: Use and in-hospital outcomes. <i>Arch Intern Med<\/i> 2010; 170: 631\u2013637.","DOI":"10.1001\/archinternmed.2010.30"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. <i>J Am Coll Cardiol<\/i> 2006; 47: 2493\u20132497.","DOI":"10.1016\/j.jacc.2006.02.049"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Reynolds DW, Ritter P. A leadless intracardiac transcatheter pacing system. <i>N Engl J Med<\/i> 2016; 374: 2604\u20132605.","DOI":"10.1056\/NEJMc1604852"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. <i>N Engl J Med<\/i> 2015; 373: 1125\u20131135.","DOI":"10.1056\/NEJMoa1507192"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Roberts PR, Clementy N, Al Samadi F, Garweg C, Martinez-Sande JL, Iacopino S, et al. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. <i>Heart Rhythm<\/i> 2017; 14: 1375\u20131379.","DOI":"10.1016\/j.hrthm.2017.05.017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ritter P, Duray GZ, Zhang S, Narasimhan C, Soejima K, Omar R, et al. The rationale and design of the Micra Transcatheter Pacing Study: Safety and efficacy of a novel miniaturized pacemaker. <i>Europace<\/i> 2015; 17: 807\u2013813.","DOI":"10.1093\/europace\/euv026"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. <i>Heart Rhythm<\/i> 2018; 15: 1800\u20131807.","DOI":"10.1016\/j.hrthm.2018.08.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Duray GZ, Ritter P, El-Chami M, Narasimhan C, Omar R, Tolosana JM, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study. <i>Heart Rhythm<\/i> 2017; 14: 702\u2013709.","DOI":"10.1016\/j.hrthm.2017.01.035"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Garg A, Koneru JN, Fagan DH, Stromberg K, Padala SK, El-Chami MF, et al. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. <i>Heart Rhythm<\/i> 2020; 17: 2056\u20132063.","DOI":"10.1016\/j.hrthm.2020.07.035"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Iwasaki YK, Noda T, Akao M, Fujino T, Hirano T, Inoue K, et al. JCS\/JHRS 2024 Guideline focused update on management of cardiac arrhythmias. <i>Circ J<\/i> 2025; 89: 1012\u20131073.","DOI":"10.1253\/circj.CJ-24-0073"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. <i>J Am Coll Cardiol<\/i> 2008; 52: 2119\u20132126.","DOI":"10.1016\/j.jacc.2008.09.018"},{"key":"13","unstructured":"13. Center for Outcomes Research and Economic Evaluation for Health National Institute of Public Health (C2H). Guideline for preparing cost-effectiveness evaluation to the Central Social Insurance Medical Council 2024. https:\/\/c2h.niph.go.jp\/tools\/guideline\/guideline_en_2024.pdf (accessed November 14, 2025)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. <i>MDM Policy Practice<\/i> 2022; 7: 23814683211061097.","DOI":"10.1177\/23814683211061097"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. <i>BMJ<\/i> 2021; 372: n71.","DOI":"10.1136\/bmj.n71"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. <i>Heart Rhythm<\/i> 2018; 15: 1800\u20131807.","DOI":"10.1016\/j.hrthm.2018.08.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study. <i>Heart Rhythm<\/i> 2012; 9: 728\u2013735.","DOI":"10.1016\/j.hrthm.2011.12.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cantillon DJ, Exner DV, Badie N, Davis K, Gu NY, Nabutovsky Y, et al. Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment. <i>JACC Clin Electrophysiol<\/i> 2017; 3: 1296\u20131305.","DOI":"10.1016\/j.jacep.2017.05.007"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shakya S, Matsui H, Fushimi K, Yasunaga H. In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan. <i>J Cardiol<\/i> 2017; 70: 405\u2013410.","DOI":"10.1016\/j.jjcc.2017.02.013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ellenbogen KA, Hellkamp AS, Wilkoff BL, Camun\u00e3s JL, Love JC, Hadjis TA, et al. Complications arising after implantation of DDD pacemakers: The MOST experience. <i>Am J Cardiol<\/i> 2003; 92: 740\u2013741.","DOI":"10.1016\/S0002-9149(03)00844-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tjong FVY, Knops RE, Udo EO, Brouwer TF, Dukkipati SR, Koruth JS, et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy: A propensity score-matched analysis. <i>Heart Rhythm<\/i> 2018; 15: 1387\u20131393.","DOI":"10.1016\/j.hrthm.2018.04.027"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: Results From the MARVEL 2 Study. <i>JACC Clin Electrophysiol<\/i> 2020; 6: 94\u2013106.","DOI":"10.1016\/j.jacep.2019.10.017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Garweg C, Splett V, Sheldon TJ, Chinitz L, Ritter P, Steinwender C, et al. Behavior of leadless AV synchronous pacing during atrial arrhythmias and stability of the atrial signals over time: Results of the MARVEL Evolve subanalysis. <i>Pacing Clin Electrophysiol<\/i> 2019; 42: 381\u2013387.","DOI":"10.1111\/pace.13615"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, et al. Comparison of prognosis and safety of pacemaker implantation in patients aged less than or 85 years and older. <i>J Interv Card Electrophysiol<\/i> 2021; 61: 171\u2013179.","DOI":"10.1007\/s10840-020-00797-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Palmisano P, Guerra F, Dell\u2019Era G, Ammendola E, Ziacchi M, Laffi M, et al. Impact on all-cause and cardiovascular mortality of cardiac implantable electronic device complications: Results from the POINTED Registry. <i>JACC Clin Electrophysiol<\/i> 2020; 6: 382\u2013392.","DOI":"10.1016\/j.jacep.2019.11.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cabanas-Grand\u00edo P, Garc\u00eda Campo E, Bisbal F, Garc\u00eda-Seara J, Pach\u00f3n M, Juan-Salvadores P, et al. Quality of life of patients undergoing conventional vs leadless pacemaker implantation: A multicenter observational study. <i>J Cardiovasc Electrophysiol<\/i> 2020; 31: 330\u2013336.","DOI":"10.1111\/jce.14322"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tjong FVY, Beurskens NEG, de Groot JR, Waweru C, Liu S, Ritter P, et al. Health-related quality of life impact of a transcatheter pacing system. <i>J Cardiovasc Electrophysiol<\/i> 2018; 29: 1697\u20131704.","DOI":"10.1111\/jce.13726"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Palmisano P, Alessandro G, Vincenzo P, Domenica CM, Valerio CM, Cesario S, et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy: Peri-procedural aspects, utilization of medical resources and patient acceptance. <i>Expert Rev Med Devices<\/i> 2021; 18: 483\u2013491.","DOI":"10.1080\/17434440.2021.1921573"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yu M, Li YP, Shi DM, Zhou YJ. Comparation of quality of life in Chinese patients undergoing leadless versus conventional pacemaker implantation. <i>Clin Cardiol<\/i> 2023; 46: 49\u201356.","DOI":"10.1002\/clc.23939"},{"key":"30","unstructured":"30. Rombach I, Banning A, Hildick-Smith D, Gray AM, Toff WD, UK TAVI Trial Investigators. Analysis of costs and quality of life at one year in the United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial. <i>In<\/i>: PCR Valves e-Course 2020, 18\u201321 November 2021, Paris, France. Paris: PCRonline; 2020."},{"key":"31","unstructured":"31. Medical Data Vision (MDV). Learning the most from Japanese medical data by using one of the largest database. https:\/\/en.mdv.co.jp\/ (accessed May 1, 2025)."},{"key":"32","unstructured":"32. Notification on Partial Revision of Specified Special Treatment Materials and Their Reimbursement Prices (Material Price Standards) 2022. https:\/\/www.mhlw.go.jp\/content\/12404000\/000907866.pdf (accessed May 1, 2025)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ara R, Brazier J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). <i>Value Health<\/i> 2008; 11: 1131\u20131143.","DOI":"10.1111\/j.1524-4733.2008.00352.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Makino K, Mudge M, Hill M, Zaunmayr C, Tilden D. Cost-effectiveness of Micra<sup>TM<\/sup> VR leadless pacemaker in patients with bradycardia and atrial fibrillation in Australia. <i>J Arrhythmia<\/i> 2024; 40: 1481\u20131489.","DOI":"10.1002\/joa3.13145"},{"key":"35","unstructured":"35. Japanese Circulation Society Joint Working Group. Guidelines for rehabilitation in society, attending school and working in patients treated with pacemaker, ICD and CRT (open only website). http:\/\/www j-circ or jp\/guideline\/pdf\/JCS2013_okumura_h pdf. 2013 (accessed July 14, 2015)."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sears SF, Jordan EW, Hashmath Z, Sargeant MM, Catanzaro J, Nekkanti R, et al. Leadless pacemakers: The \u201cleading edge\u201d of quality of life in cardic electrophysiology. <i>Cur Cardiol Rep<\/i> 2025; 27: 77.","DOI":"10.1007\/s11886-025-02228-5"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. El-Chami MF, Garweg C, Clementy N, Al-Samadi F, Iacopino S, Martinez-Sande JL, et al. Leadless pacemakers at 5-year follow-up: The Micra transcatheter pacing system post-approval registry. <i>Eur Heart J<\/i> 2024; 45: 1241\u20131251.","DOI":"10.1093\/eurheartj\/ehae101"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Haeberlin A, Kozhuharov N, Knecht S, Tanner H, Schaer B, Noti F, et al. Leadless pacemaker implantation quality: Importance of the operator\u2019s experience. <i>Europace<\/i> 2020; 22: 939\u2013946.","DOI":"10.1093\/europace\/euaa097"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Valiton V, Graf D, Pruvot E, Carroz P, Fromer M, Bisch L, et al. Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: Initial Swiss experience from the Romandie region. <i>Europace<\/i> 2019; 21: 275\u2013280.","DOI":"10.1093\/europace\/euy195"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Banz K, Delnoy PP, Billuart JR. Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: A multinational economic evaluation. <i>Health Econ Rev<\/i> 2015; 5: 57.","DOI":"10.1186\/s13561-015-0057-3"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: Systematic review and economic evaluation. <i>Health Technol Assess<\/i> 2005; 9: iii, xi\u2013xiii, 1\u2013246.","DOI":"10.3310\/hta9430"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Deniz HB, Caro JJ, Ward A, Moller J, Malik F. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy. <i>J Cardiovasc Med (Hagerstown)<\/i> 2008; 9: 43\u201350.","DOI":"10.2459\/JCM.0b013e328013cd28"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hagiwara H, Nagai N, Otsubo K, Sasaki S, Aoyagi H, Chiba Y, et al. Real-world long-term effectiveness of implantable cardioverter-defibrillators in elderly patients. <i>Circ Rep<\/i> 2025; 7: 15\u201324.","DOI":"10.1253\/circrep.CR-24-0131"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kondo Y, Chiba T, Osawa M, Kawasaki Y, Goto T, Coles JA Jr, et al. Medical cost analysis of implantable cardioverter defibrillators for primary prevention among cardiac arrest patients. <i>Circ J<\/i> 2026; 90: 118\u2013125.","DOI":"10.1253\/circj.CJ-25-0195"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/7\/8_CR-26-0090\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:28:28Z","timestamp":1783740508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/7\/8_CR-26-0090\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0090","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"CR-26-0090"}}